Daily FNArena News - Treasure Chest

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Is there an opportunity in outdoor advertiser oOh!media? Goldman Sachs joins the believers, initiating coverage of the stock

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Will Xero’s stellar growth in accounting software start to wane? Beyond FY22, brokers appear to be lining up on opposing sides

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.? Computershare is highly leveraged to the interest rate cycle so is it time to start factoring in higher rates?

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. While some views on Nanosonics remain positive, recent research highlights the company may become a victim of prior success

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Insurance Australia Group may be in line for a re-rating as the prospect of a cyclical recovery is getting better

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts.? Boral will sell its North American building products business, ex fly ash, adding complexity in the face of the offer from Seven Group

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. With a growth rate three times that of sector peers, Uniti Group is set to benefit from the scale afforded by recent acquisitions

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Pfizer will now distribute its PBS medicines via a wholesale model and Ebos Group is one wholesaler/distributor that will benefit

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Amidst divergent views on Nanosonics, Bell Potter has identified the company as a primary victim of global covid restrictions and delays

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. As mobility across the US improves, attendance at CSL’s plasma collection centres is turning around, providing more optimism about the outlook